ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 82 filers reported holding ANTARES PHARMA INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2015 | $321,000 | – | 265,425 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JW Asset Management, LLC | 1,820,524 | $4,697,000 | 3.00% |
ARMISTICE CAPITAL, LLC | 12,050,000 | $31,089,000 | 2.03% |
Broadfin Capital, LLC | 4,623,247 | $11,928,000 | 1.88% |
Healthcare Value Capital, LLC | 100,000 | $258,000 | 0.73% |
Healthcare Value Capital, LLC | 100,000 | $258,000 | 0.73% |
MYCIO WEALTH PARTNERS, LLC | 2,433,500 | $6,278,000 | 0.65% |
PERKINS CAPITAL MANAGEMENT INC | 317,500 | $819,000 | 0.59% |
Brown Advisory Securities, LLC | 275,000 | $710,000 | 0.12% |
FALCON POINT CAPITAL, LLC | 222,501 | $574,000 | 0.11% |
Avenir Corp | 291,597 | $752,000 | 0.09% |